Basic Information
VIS ID
TVIS20004422
Fusion event
HPV-PNRC1 integration
Validated
Yes
Detection method
APOT-PCR
Data source
Curated
Sample type
Disease
Oropharyngeal squamous cell carcinoma (OSCC)
Quality evaluation
Normal
Reported year
2014
PubMed ID
Virus Sequence
Virus name
HPV
Subtype
HPV16
Reference genome
Host Sequence
Chromosome
chr6
Cytoband
q15
Reference genome
End
89790877/89081158 (Hg38)
Orient
+
Location type
Intron1
Fragile sites / regions
Target gene
miRNAs that regulate target gene
hsa-mir-335-5p ; hsa-mir-98-5p ; hsa-mir-1250-5p ; hsa-mir-423-5p ; hsa-mir-100-5p ; hsa-let-7a-5p ; hsa-mir-19a-3p ; hsa-mir-19b-3p ; hsa-mir-199a-3p ; hsa-mir-199b-3p ; hsa-mir-222-5p ; hsa-mir-130a-3p ; hsa-mir-301a-3p ; hsa-mir-130b-3p ; hsa-mir-454-3p ; hsa-mir-301b-3p ; hsa-mir-936 ; hsa-mir-3129-5p ; hsa-mir-4295 ; hsa-mir-3666 ; hsa-mir-4671-3p ; hsa-mir-26a-5p ; hsa-mir-26b-5p ; hsa-mir-106a-3p ; hsa-mir-513c-5p ; hsa-mir-466 ; hsa-mir-514b-5p ; hsa-mir-3941 ; hsa-mir-4672 ; hsa-mir-6750-3p ; hsa-mir-362-3p ; hsa-mir-329-3p ; hsa-mir-603 ; hsa-mir-8485 ; hsa-mir-3148 ; hsa-mir-3201 ; hsa-mir-4668-5p ; hsa-mir-4791 ; hsa-mir-548g-3p ; hsa-mir-548av-3p ; hsa-mir-4307 ; hsa-mir-6739-5p ; hsa-mir-6733-5p ; hsa-mir-3153 ; hsa-mir-6837-5p ; hsa-mir-4685-5p ; hsa-mir-7113-5p ; hsa-mir-6871-5p ; hsa-mir-4425 ; hsa-mir-5089-5p ; hsa-mir-5589-5p ; hsa-mir-4731-5p ; hsa-mir-6506-5p ; hsa-mir-619-5p ; hsa-mir-150-5p ; hsa-mir-186-3p ; hsa-mir-6849-3p ; hsa-mir-1226-3p ; hsa-mir-520h ; hsa-mir-520g-3p ; hsa-mir-512-3p ; hsa-mir-520e ; hsa-mir-520d-3p ; hsa-mir-520c-3p ; hsa-mir-520b ; hsa-mir-520a-3p ; hsa-mir-373-3p ; hsa-mir-372-3p ; hsa-mir-302e ; hsa-mir-302d-3p ; hsa-mir-302c-3p ; hsa-mir-302b-3p ; hsa-mir-302a-3p ; hsa-mir-93-5p ; hsa-mir-526b-3p ; hsa-mir-519d-3p ; hsa-mir-20b-5p ; hsa-mir-20a-5p ; hsa-mir-17-5p ; hsa-mir-106b-5p ; hsa-mir-106a-5p ; hsa-mir-578 ; hsa-mir-211-5p ; hsa-mir-204-5p ; hsa-mir-3667-3p ; hsa-mir-5582-3p ; hsa-mir-5088-3p ; hsa-mir-548x-3p ; hsa-mir-548j-3p ; hsa-mir-548aq-3p ; hsa-mir-548am-3p ; hsa-mir-548aj-3p ; hsa-mir-548ah-3p ; hsa-mir-548ae-3p ; hsa-mir-548z ; hsa-mir-548h-3p ; hsa-mir-548d-3p ; hsa-mir-548bb-3p ; hsa-mir-548ac ; hsa-mir-335-3p ; hsa-mir-664b-3p ; hsa-mir-579-3p ; hsa-mir-5696 ; hsa-mir-1250-3p ; hsa-mir-6807-5p ; hsa-mir-1304-3p ; hsa-mir-6872-3p ; hsa-mir-4267 ; hsa-mir-3680-5p ; hsa-mir-5591-3p ; hsa-mir-6735-3p ; hsa-mir-122-5p ; hsa-mir-3151-3p ; hsa-mir-3677-5p ; hsa-mir-6854-5p ; hsa-mir-4482-5p ; hsa-mir-3130-5p ; hsa-mir-1912 ; hsa-mir-1295b-5p ; hsa-mir-129-5p ; hsa-mir-489-3p
Nearest miRNA
hsa-mir-10398/Upstream/10541849; hsa-mir-1202/Downstream/1231584;
Nearest CpG islands
chr6-CpG: 149/Target, None/Upstream, None/Downstream
Upstream sequence
CTTTTCCTCCCGAGGTTACTTTGGGGCCCTCCCGATGGTGACCACGGCTCCGCCTCCTTTACCCCGGATCCCGGACCCCCGGGCACTGCCCCCGACCCTC
Downstream sequence
ACTCCTCGGGCAGCGCCGAAGAAGCGGCGAAAGAAGAAGGTGCGGGCCAGCCCCGCAGGGCAGCTGCCCAGCCGCTTCCACCAGTACCAGCAGCACCGGC
Target sequence
TTCCTCCCTCATTTCCTAGGGGGAGATGGCCCGTGTCTGACCCCCCAGCCTCGCGCTCCAGCAGCTCTGCCCAACCGCAGCCTCGCCGTGGCGGGAGGC
Reference
Olthof, N. C., et al.Comprehensive analysis of HPV16 integration in OSCC reveals no significant impact of physical status on viral oncogene and virally disrupted human gene expression.2014, PLoS One 9(2): e88718.
Curate